DAISY – Specific Aim 3

This project aims to measure acceptability of, and preferences for the DAISY drug delivery platform among two key end-user groups in South Africa (SA): caregivers of HIV-positive children receiving antiretroviral therapy (ART) and health care providers.

These end-user perspectives are linked to the Target Product Profile (TPP) and will inform design of the DAISY, including device and applicator characteristics.

Latest Update:

April 2024

For more about DAISY – Specific Aim 3 please email

Research Brief

DAISY – Specific Aim 3

Stay up to date

Get updates on news, resources, events and happenings from Wits RHI.